Page All:
Page 1
The Evolving E-Prescribing Landscape: Deloitte
What:
"The Evolving E-Prescribing Landscape: Challenges, Incentives and the Opportunities for Industry Stakeholders"
Who:
Russ Rudish, vice chairman and Deloitte's health care providers sector leader
Dr. Mitchell Morris, principal, Deloitte Consulting LLP
Tony Obey, principal, Deloitte Consulting LLP
Todd Shores, senior manager, Deloitte Consulting LLP
When:
Available immediately
Where:
http://www.deloitte.com/us/eprescribing
Details:
As annual increases in health care costs continue to outpace inflation, private insurers, public programs and consumers are challenging health care providers to incorporate technology solutions, such as electronic health records (EHR), as part of their cost reduction strategy.
"One underutilized technology that has gained the attention of policy makers and was included as part of the 2009 stimulus package is e-prescribing," said Obey. "The benefit opportunities of e-prescribing include the potential to reduce both prescription drug costs and adverse drug events."
The white paper discusses the following:
-- A history of e-prescription, including the effects of the 2009
stimulus package and the HITECH provisions on the definition of
e-prescription.
-- The e-prescribing process and participants.
-- The current e-prescribing landscape, including:
-- Where e-prescription fits in the EHR landscape
-- The regulatory environment
-- Marketplace strategies and stakeholder incentives for hospitals
and health systems, medical groups, pharmacies, payers and
prescription aggregators
-- Includes sample collaborative programs
-- Critical e-prescribing challenges, including:
-- Implementation
-- Financing
-- Messaging standards
-- Regulatory environment
-- Data privacy
-- Successful e-prescribing implementation
"The benefit opportunities of implementing electronic health records and e-prescribing are clear to us," said Obey. "These technologies could potentially save lives, prevent patient harm by providing access to a patient's entire medical history, and save billions of dollars in annual health care expenditures. Yet the path to achieving this goal is less apparent and paved with a complexity of requirements."
To download a copy of the paper, please go to: http://www.deloitte.com/us/eprescribing
Please contact John Pappas at jpappas@deloitte.com or (212) 492-3922 to schedule an interview.
About Deloitte
As used in this document, "Deloitte" means Deloitte Consulting LLP and Deloitte Services LP, which are separate subsidiaries of Deloitte LLP. Please see http://www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
CONTACT: John Pappas, Public Relations, Deloitte, +1-212-492-3922, jpappas@deloitte.com
/PRNewswire -- March 2/
Source: Deloitte
Web Site: http://www.deloitte.com/us/eprescribing
The Evolving E-Prescribing Landscape: Deloitte
What:
"The Evolving E-Prescribing Landscape: Challenges, Incentives and the Opportunities for Industry Stakeholders"
Who:
Russ Rudish, vice chairman and Deloitte's health care providers sector leader
Dr. Mitchell Morris, principal, Deloitte Consulting LLP
Tony Obey, principal, Deloitte Consulting LLP
Todd Shores, senior manager, Deloitte Consulting LLP
When:
Available immediately
Where:
http://www.deloitte.com/us/eprescribing
Details:
As annual increases in health care costs continue to outpace inflation, private insurers, public programs and consumers are challenging health care providers to incorporate technology solutions, such as electronic health records (EHR), as part of their cost reduction strategy.
"One underutilized technology that has gained the attention of policy makers and was included as part of the 2009 stimulus package is e-prescribing," said Obey. "The benefit opportunities of e-prescribing include the potential to reduce both prescription drug costs and adverse drug events."
The white paper discusses the following:
-- A history of e-prescription, including the effects of the 2009
stimulus package and the HITECH provisions on the definition of
e-prescription.
-- The e-prescribing process and participants.
-- The current e-prescribing landscape, including:
-- Where e-prescription fits in the EHR landscape
-- The regulatory environment
-- Marketplace strategies and stakeholder incentives for hospitals
and health systems, medical groups, pharmacies, payers and
prescription aggregators
-- Includes sample collaborative programs
-- Critical e-prescribing challenges, including:
-- Implementation
-- Financing
-- Messaging standards
-- Regulatory environment
-- Data privacy
-- Successful e-prescribing implementation
"The benefit opportunities of implementing electronic health records and e-prescribing are clear to us," said Obey. "These technologies could potentially save lives, prevent patient harm by providing access to a patient's entire medical history, and save billions of dollars in annual health care expenditures. Yet the path to achieving this goal is less apparent and paved with a complexity of requirements."
To download a copy of the paper, please go to: http://www.deloitte.com/us/eprescribing
Please contact John Pappas at jpappas@deloitte.com or (212) 492-3922 to schedule an interview.
About Deloitte
As used in this document, "Deloitte" means Deloitte Consulting LLP and Deloitte Services LP, which are separate subsidiaries of Deloitte LLP. Please see http://www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
CONTACT: John Pappas, Public Relations, Deloitte, +1-212-492-3922, jpappas@deloitte.com
/PRNewswire -- March 2/
Source: Deloitte
Web Site: http://www.deloitte.com/us/eprescribing